Literature DB >> 9217410

Buspirone in the management of disruptive behaviors due to Huntington's disease and other neurological disorders.

A N Bhandary1, P S Masand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9217410     DOI： 10.1016/S0033-3182(97)71447-6

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  6 in total

1.  Treatment of huntington disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 2.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

3.  Treatment of Irritability in Huntington's Disease.

Authors:  Erik van Duijn
Journal:  Curr Treat Options Neurol       Date:  2010-07-10       Impact factor: 3.598

4.  An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease.

Authors:  Mark Groves; Erik van Duijn; Karen Anderson; David Craufurd; Mary C Edmondson; Nathan Goodman; Daniel P van Kammen; Lavonne Goodman
Journal:  PLoS Curr       Date:  2011-08-30

Review 5.  Cell Therapy Strategies vs. Paracrine Effect in Huntington's Disease.

Authors:  Wooseok Im; Manho Kim
Journal:  J Mov Disord       Date:  2014-04-30

Review 6.  Irritability in Huntington's Disease.

Authors:  Nicholas E Karagas; Natalia Pessoa Rocha; Erin Furr Stimming
Journal:  J Huntingtons Dis       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.